330 results about "Pyridoxine" patented technology

An improved ultra-high fiber supplement that promotes satiety, caloric reduction, and weight loss. The supplement comprises guar, oat, psyllium, locust bean gum, pectin, green tea, multi-anthocyanadins, pyridoxine, and folic acid. It improves cardiovascular health and reduces cardiovascular inflammation and the risk of heart disease. The addition of antioxidants, including green tea, improves weight loss, and general and cardiovascular health. Also it reduces serum lipoprotein oxidation and risk of free-radical related diseases. Additional benefits include the lowering of plasma homocysteine by the addition of folic acid and pyridoxine. Consumption of the supplement aids in reducing absorption and assimilation of ingested toxins. A method of providing an ultra-high fiber comestible that is highly palatable and can be used to supplement nutrition and to manage and prevent diet-related diseases is disclosed. Further embodiments increase fiber and other nutrients in the diet and helps manage and prevent all diet-related diseases.

A dietary supplement of mitochondrial nutrients is designed for relieving stress, preventing and improving stress-related disorders, such as chronic fatigue syndrome, diabetes, age-associated cognitive dysfunction and diseases (Parkinson's and Alzheimer's disease). The supplement composition has the following nutrients: B vitamins (cyanocobalamin 2-1,000 ug, thiamin 1-1,000 mg, niacin 15-2,000 mg, pyridoxine 1-1,000 mg, Pantothenate 5-150 mg, folic acid 400-40,000 ug), alpha-tocopherol 10-800 mg, ascorbic acid 50-10,000 mg, calcium 20-2,000 mg, vitamin A 200-10,000 ug, alpha-lipoic acid 100-1,000 mg, N-acetyl cysteine 100-3,000 mg, L-carnosine 100-9,000 mg, tyrosine 100-9,000 mg, vanillin 10-100 mg, phosphatidylserine 10-800 mg, resveratrol 10-50 mg, dehydroepiandrosterone 1-50 mg, and melatonin 0.1-3 mg, all of which have been individually used experimentally or clinically for relieving stress, preventing and treating age- and stress-related disorders and diseases but no combination of these compounds has been used. Many embodiments also contain at least one adjunct ingredient such as coenzyme Q 10-200 mg, acetyl-L-carnitine 100-2,000 mg, choline 50-1,000 mg, and creatine 100-2,000 mg.

Compounds with antiplatelet aggregation and anticoagulant characteristics for the treatment of cardiovascular, cerebrovascular, and cardiovascular related diseases and symptoms, are described. The methods are directed to administering pharmaceutical compositions comprising aryl sulfonic pyridoxine and/or substituted pyridoxine analogs.

An improved ultra-high fiber supplement that promotes satiety, caloric reduction, and weight loss. The supplement comprises guar, oat, psyllium, locust bean gum, pectin, green tea, multi-anthocyanadins, pyridoxine, and folic acid. The supplement can exist as a liquid, semi-solid, or solid comestible. It improves cardiovascular health and reduces cardiovascular inflammation and the risk of heart disease. The addition of antioxidants, including green tea, improves weight loss, and general and cardiovascular health. Also it reduces serum lipoprotein oxidation and risk of free-radical related diseases. Consumption of the supplement aids in reducing absorption and assimilation of ingested toxins. A method of providing an ultra-high fiber comestible that is highly palatable and can be used to supplement nutrition and to manage and prevent diet-related diseases is disclosed. Further embodiments increase fiber and other nutrients in the diet and helps manage and prevent all diet-related diseases.

The present invention relates to compositions of and methods for producing timed or retarded release formulations that contain green coffee extract, and optionally vinpocetine, L-camitine, of amylase inhibitor, niacin, Vitamin B3 (niacinamide), vitamin B6 (pyridoxine hydrocholoride), vitamin B12 (cyanocobaolamin), vitamin B5 (pantothenic acid), inositol, phosphorus, iodine, and chromium and/or their dietary and nutraceutically acceptable salts of the same and/or hydrates of the active substance that provide a timed or retarded release formulation of the active substance.

The invention discloses a plant seed soaking and dressing agent, and relates to the technical field of crop seed soaking and dressing. The plant seed soaking and dressing agent is prepared from the raw materials of ferrous lactate, zinc lactate, thiamine, pyridoxine, nicotinamide, pine needle, light yellow sophora root and sweet wormwood by the following steps: A, mixing and smashing pine needle, light yellow sophora root and sweet wormwood, putting the mixture into 450-550ml of 70-90 percent ethanol for soaking for 10-20 days, pressing, filtering and removing residues to form a liquid medicament; B, putting ferrous lactate, zinc lactate, thiamine, pyridoxine and nicotinamide into the liquid medicament to form a seed soaking and dressing raw liquid; and C, adding water to blend into 5,000ml of diluted liquid medicament, and sealing the diluted liquid medicament for 20 hours to form the seed soaking and dressing agent. The plant seed soaking and dressing agent has the beneficial effects that through scientific matching of various insect-killing, sterilizing and body-strengthening elements, the resistance of seeds is enhanced, and an environment which is low in the quantity of insects and bacteria is created, so that healthy growth of seeds is ensured, plant diseases and insect pests are reduced, cold resistance and disease resistance are realized, robust growth of seedlings is ensured, and great social economical significance is achieved.

The present invention relates to compositions without added iron and methods for prophylactic nutritional supplementation and therapeutic nutritional supplementation. Specifically, the method involves administering to an individual a composition comprising carotenoids, vitamin E, vitamin D, vitamin C, thiamine, riboflavin, niacin, folic acid, pyridoxine, biotin, pantothenic acid, cobalamin, magnesium, manganese, zinc, selenium, chromium, copper, alpha lipoic acid, and lutein, wherein the composition is free of added iron.

Method is provided of treating or preventing hypertrophy, hypertension, myocardial ischemia, ischemic heart disease, myocardial infarction, congestive heart failure, organ ischemia, tissue ischemia, acute coronary syndrome, unstable angina, ischemia reperfusion injury, preventing death subsequent to myocardial infarction, cerebral infarction, contractile dysfunction subsequent to myocardial infarction, or arrhythmia in a mammal with low doses of pyridoxine, pyridoxal-5′phosphate, pyridoxal or pyridoxamine. Compositions and kits for said method is also included.

The invention a bletilla striata differentiation and seedling strengthening medium and relates to the technical field of bletilla striata planting and cultivation. The bletilla striata differentiation and seedling strengthening medium is prepared from the following raw materials including potassium nitrate, 440-490mg of ammonium sulfate, monopotassium phosphate, magnesium sulfate, calcium chloride, manganese sulfate, zinc sulfate, boric acid, potassium iodide, sodium molybdate, copper sulfate, cobalt chloride, ferrous sulfate, EDTA (Ethylene Diamine Tetraacetic Acid), phaseomannite, thiamine sulfate, pyridoxine sulfate, nicotinic acid, glycine, DMPT, sodium para-nitrophenolate, sodium ortho-nitrophenol, 5-nitroguaiacol sodium salt, 6-BA, NAA, PP-333, CPPU, citric acid, and cane sugar under a proper pH value condition. The bletilla striata differentiation and seedling strengthening medium can improve the differentiation effects of bletilla striata seeds, and promotes the growth of seedlings and the fast formation of pseudobulb, so that the germination rate of the seeds can be effectively increased, and the growth speed of an embryoid can be increased.

A method of treating angina in a mammal includes administering pyridoxal-5′-phosphate, pyridoxal, pyridoxine, pyridoxamine, 3-acylated analogues of pyridoxal, 3-acylated analogues of pyridoxal-4,5-aminal, pyridoxine phosphonate analogues, or pharmaceutical compositions thereof.

A method of treating a cerebrovascular disease, particularly stroke, is described. A method of treating a cerebrovascular disease includes administering pyridoxal-5'-phosphate, pyridoxal, pyridoxine, pyridoxamine, 3-acylated analogues of pyridoxal, 3-acylated analogues of pyriodoxal-4,5-animal, pyridoxine phosphonate analogues, or pharmaceutical compositions thereof.

The present invention relates to improved ophthalmic solutions that employ select B vitamins; pyridoxine and its salts; and thiamine and its salts in order to more effectively preserve solutions and to reduce the degree to which cationic preservatives will deposit on contact lenses. Ophthalmic solutions are here understood to include contact lens treatment solutions, such as cleaners, soaking solutions, conditioning solutions and lens storage solutions, as well as wetting solutions and in-eye solutions for treatment of eye conditions.

The invention discloses a ginkgo toxicity removal method based on a physical and enzymatic combination method. Through screening of substantial experiments, toxic component degrading enzymes of ginkgoes are used for bioconversion at the optimal temperature under optimal moisture conditions, toxic component 4-0-methyl pyridoxine and cyanogentic glycoside type components of the ginkgoes are removed efficiently, allergic protein in the ginkgoes are denatured and inactivated through high-temperature treatment, degraded products of the cyanogentic glycoside components are evaporated and removed, toxic component ginkgo acid is removed, moisture of the ginkgoes is reduced to some extent according to distribution of the ginkgo acid in the ginkgoes, and germ positions with the most gingko acid are removed manually or mechanically. The ginkgo toxicity removal method has the advantages of reasonableness in overall process design, high detoxification efficiency, environment protection, safety, non-existence of residual solvent, convenience in operation, low cost and capabilities of overcoming defects in the prior art and achieving industrial production.

A method of modulating cell death includes administering pyridoxal-5′phosphate, pyridoxal, pyridoxine, pyridoxamine, 3-acylated analogues of pyridoxal, 3-acylated analogues of pyridoxal-4,5-aminal, pyridoxine phosphonate analogues, or pharmaceutical compositions thereof.

Aryl sulfonic pyridoxine compounds with antiplatelet aggregation characteristics for the treatment of cardiovascular and cardiovascular related disease, are described. The methods are directed to administering pharmaceutical compositions comprising aryl sulfonic pyridoxines.

Compounds with antiplatelet aggregation characteristics for the treatment of cardiovascular and cardiovascular related disease, are described. The methods are directed to administering pharmaceutical compositions comprising a pyridoxine analogue.

The present invention relates to compositions and methods for prophylactic nutritional supplementation and therapeutic nutritional supplementation. Specifically, the composition provides a nutritional supplement with a beneficial increased supplementation of vitamin D and the method involves administering to an individual a composition comprising carotenoids, vitamin E, vitamin D, vitamin C, thiamine, riboflavin, niacin, folic acid, pyridoxine, biotin, pantothenic acid, cobalamin, magnesium, manganese, zinc, selenium, chromium, copper, alpha lipoic acid, and lutein.

The invention discloses a method for processing cider wine containing more ester. According to the method, the content of ester in the cider wine is increased through adjusting and controlling the variety and content of nutrients in normal apple juice; according to a further study, the content of ester in the cider wine can be effectively increased through adding leucine, glutamine, pyridoxine and zinc chloride to the normal apple juice. Various appropriate nutrients such as amino acids, microelement and vitamins are added to the normal apple juice, so that more precusor substances for fermentation and generating metabolites are provided for saccharomycetes, the cider wine is enabled to accumulate more ester during the fermentation process, ester fragrance is increased, and the quality of the cider wine is improved.

Aiming to provide an anti-acne skin care product characterized by good stability, small irritation and applicability to sensitive skin, the invention discloses a skin care product with soothing and anti-acne efficacy. The skin care product comprises an active component and a substrate, and the active component includes the following components by mass percentage: 0.5-2% of gellan gum, 0.3-2.5% of sodium shale oil sulfonate, 0.1-1% of glycerophosphoinositol choline, and 0.5-3% of acne removal agent, wherein the acne removal agent is composed of capryloyl glycine, capryloyl salicylic acid, tocopheryl phosphate, a Chinese trumpet creeper extract, matrine and pyridoxine in a mass ratio of 1:1.5:1:2:1:1. The skin care product belongs to the field of cosmetics.

A nutritional supplement comprising at least a therapeutically effective amount of pyridoxine α-hydroxyisocaproate is provided by the present invention. The ingredients of the present nutritional supplement act substantially simultaneously to maintain physiological blood and muscular pH and increase the time to muscular fatigue in a mammal during periods of repetitive forceful muscular exercise. A method of use is provided by the present disclosure.

The present invention relates to improved ophthalmic solutions that employ select B vitamins; pyridoxine and its salts; and thiamine and its salts in order to more effectively preserve solutions and to reduce the degree to which cationic preservatives will deposit on contact lenses. Ophthalmic solutions are here understood to include contact lens treatment solutions, such as cleaners, soaking solutions, conditioning solutions and lens storage solutions, as well as wetting solutions and in-eye solutions for treatment of eye conditions.

Preeclampsia and intrauterine growth restriction in a pregnant female mammal are prevented or decreased in severity by administering thereto a combination of a vitamin compound containing B1, Folic Acid (or active form 5-Methyl-Tetrahydrofolate i.e.; Metafolin®), B 6 (Pyridoxine or active form Pyridoxine 5-Phosphate P5P), B 12, Ascorbic Acid, Selenium, Zinc, Co-enzyme Q 10 and N-Acytyl Cysteine, Lycopene, optionally in further combination with Melatonin and/or Vitamin E or/and ASA 81 mg both of later, are cyclooxygenase inhibitors, a PGI.sub.2-mimetic, a thromboxane (TXA.sub.2) inhibitor, a compound possessing TXA.sub.2-agonistic and TXA.sub.2-inhibiting properties, a compound possessing TXA.sub.2-antagonistic and PGI.sub.2-mimetic activities, and a TXA.sub.2 antagonist.

The invention provides hair loss preventing shampoo and a preparation method thereof, and relates to the field of daily chemicals. The raw materials of the hair loss preventing shampoo comprise a fresh ginger extract, a radix sophorae yellowish sophora root extract, a platycladus orientalis branch tip and leaf extract, a rhizoma ligustici wallichii extract, sodium laureth sulfate, cocamide MEA, ethylene glycol distearate, cetearyl alcohol, cocamidopropyl betaine, Guar hydroxypropyltrimonium chloride, polyquaternary ammonium salt-10, sodium hyaluronate, citric acid, zinc pyrithione, dimethiconol, pyridoxine, carbomer, panthenol, phenoxyethanol, sodium benzoate, EDTA-disodium, CI16255, CI19140, CI42090, essence and the balance water. The shampoo prepared by a simple and convenient preparation method does not have nonirritant and sensitization effects on bodies, besides, is high in hair loss resistance and itching relieving properties and meets sense organ requirements of common people.

The invention concerns agonist anti-trkC antibodies, polypeptides, and polynucleotides encoding the same. The invention further concerns use of such antibodies, polypeptides and/or polynucleotides in the treatment and/or prevention of neuropathies, such as sensory neuropathies, including taxol-induced sensory neuropathy, cisplatin-induced sensory neuropathy, and pyridoxine-induced sensory neuropathy.